Singapore-US Strategic Dialogue on Biosecurity

Abstract

Singapore is poised to be a critical partner to the US in minimizing biosecurity challenges in Southeast Asia. As a nation, it is vulnerable to both emerging infectious disease and potential terrorism in the region. In addition to its geographical importance within the Asia-Pacific region, Singapore is a rising powerhouse in biotechnology, having invested $13.2B in biotech R&D from 2011-2015. As a result, it has become an attractive site for international biotechnology companies like Novartis, as well as world-class research universities. It is home to government and academic expertise capable of identifying and responding to biosecurity challenges. Its expertise is, in many ways, complementary to that of the US in these realms.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2014
Accession Number
ADA612377

Entities

People

  • Anita Cicero
  • Gigi K. Gronvall
  • Ryan Morhard
  • Sanjana Ravi
  • Tom Inglesby

Organizations

  • University of Pittsburgh Medical Center

Tags

DTIC Thesaurus Topics

  • Biological Sciences
  • Biosafety
  • Biotechnology
  • Disease Outbreaks
  • Health Services
  • Homeland Security
  • Infectious Diseases
  • Law
  • Medical Personnel
  • National Security
  • Public Health
  • Risk
  • Sars
  • Scientists
  • Teamwork
  • United States
  • Weapons Of Mass Destruction

Readers

  • Defense Technology Research and Development.
  • East Asian Political and Security Studies within the Soviet Union
  • Infectious Disease/Epidemiology

Technology Areas

  • Biotechnology